文献速递头颈部肿瘤放疗放疗物理与技术

放疗质量保证能否改善中低收入国家鼻咽癌疗效:IAEA E33039研究第二阶段技术结果

Can Radiation Therapy Quality Assurance Improve Nasopharyngeal Cancer Outcomes in Low and Middle-Income Countries-Reporting the Technical Component of the Second Phase of a Prospective International Atomic Energy Agency study (E33039).
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2025-09-05

该研究评估放疗质量保证(RT QA)项目能否改善中低收入国家鼻咽癌患者疗效。第二阶段纳入9个中心153例患者,结果显示不可接受计划率从第一阶段的64%降至11%,提示RT QA与教育可显著减少重大放疗方案偏差。

要点

  • 第二阶段不可接受计划率为11%(17/153),较第一阶段64%明显下降。
  • 治疗前审查的105例中29.5%因优先1结构重大偏差不可接受,其中66.7%重新提交后获接受。
  • 治疗后审查的48例中12.5%不可接受,整体偏差率大幅降低。

核心结论

  • 在中低收入国家,对鼻咽癌放疗计划实施RT QA与教育可大幅减少重大放疗方案偏差,有望转化为患者疗效改善。

研究设计与样本

  • 国际原子能机构E33039前瞻性研究第二阶段,2020年4月至2023年4月从9个中心纳入153例鼻咽癌患者。
  • 第一阶段曾由专家组审核134例中低收入国家鼻咽癌患者放疗计划,并向各中心反馈详细RT QA报告及面对面教育研讨会。
  • 第二阶段技术部分主要终点为优先1参数重大偏差数量与第一阶段的比较。

主要发现

  • 第二阶段153例中,105例(68.6%)按方案进行治疗前审查,48例(31.4%)因技术原因在治疗后审查(不符合方案)。
  • 治疗前审查的105例中31例(29.5%)因优先1结构重大偏差不可接受,其中30例重新提交,20例获接受(改善20/30,66.7%)。
  • 治疗后审查的48例中6例(12.5%)不可接受,第二阶段整体不可接受计划率为11%(17/153),第一阶段为64%。

关键数值与推荐

  • 第一阶段134例鼻咽癌放疗计划中不可接受计划率为64%。
  • 第二阶段治疗前审查不可接受率29.5%(31/105),重新提交后接受率66.7%(20/30)。
  • 第二阶段治疗后审查不可接受率12.5%(6/48),整体不可接受率11%(17/153)。

临床怎么用

  • 在中低收入国家鼻咽癌放疗中,应建立专家审核反馈与面对面教育相结合的RT QA程序。
  • 优先1结构的重大偏差是治疗前计划不可接受的主要原因,应作为QA重点。
  • 治疗前审查允许重新提交计划,可提高计划接受率。

局限性

  • 第二阶段48例(31.4%)因技术原因在治疗后审查,未按方案进行治疗前审查。
  • 原文未报告患者生存结局,RT QA对疗效的改善为期望性结论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Most of new nasopharyngeal cancer (NPC) cases occur in low- and middle-income countries (LMICs), but these patients experience poorer survival than new NPC cases in high income countries. This study seeks to determine whether a radiation therapy quality assurance (RT QA) program can improve patients with NPC outcomes in LMICs. Here we report the technical results of the second phase of the International E33039 study. METHODS AND MATERIALS: Phase 1 of this study included an audit by an expert panel of 134 NPC patients' RT plans from LMICs. It was previously reported and showed a 64% rate of unacceptable plans. Detailed RT QA reports was given to each center, followed by an educational face-to-face workshop discussing the results and improvement plans. Thereafter accrual for phase 2 commenced. The primary endpoint of the technical component of phase 2 is the number of major deviations in priority 1 parameters as compared with phase 1. RESULTS: A total of 153 patients accrued from 9 centers between April 2020 and April 2023 in phase 2. Notably, 105 (68.6%) were reviewed pretreatment as per protocol, and 48 (31.4%) were reviewed after treatment (not per protocol, because of technical reasons). Of the plans reviewed pretreatment, 31 of 105 (29.5%) were unacceptable because of major deviations in priority one structures. Thirty cases (30/31, 96.8%) were resubmitted and 20 were deemed acceptable (an improvement of 20/30, 66.7%). Of the plans reviewed posttreatment, 6/48 (12.5%) were unacceptable. The overall rate of unacceptable plan was 11% (17/153) in phase 2 compared with 64% in phase 1. CONCLUSIONS: This prospective study shows that RT QA and education for NPC RT plans in LMICs can dramatically reduce major RT protocol deviations. This will hopefully translate into improved patient outcomes.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Corry J, Ng WT, Moore A, et al. Can Radiation Therapy Quality Assurance Improve Nasopharyngeal Cancer Outcomes in Low and Middle-Income Countries-Reporting the Technical Component of the Second Phase of a Prospective International Atomic Energy Agency study (E33039). Int J Radiat Oncol Biol Phys. 2025. PMID: 40915434. doi:10.1016/j.ijrobp.2025.08.057

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。